Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Mental Health

Five supplements that may help with depression

by The Conversation
August 25, 2014
in Mental Health
Share on TwitterShare on Facebook
Don't miss out! Follow PsyPost on Bluesky!

By Jerome Sarris, University of Melbourne

Over two-thirds of Australians are thought to use complementary medicines ranging from vitamin and mineral supplements to herbal to aromatherapy and homeopathic products. Mental health concerns are one of the reasons why people use supplements, but are they really useful?

While there’s evidence for the efficacy of some supplements as potential treatments for depression, there’s none for others, and some have been found to be ineffective. But effectiveness is not the only concern – the quality and cost of unregulated products can also be problematic.

And then there’s the issue of discerning between bone fide evidence from double-blind randomised controlled trials and slick company marketing campaigns.

Of the supplements that have been studied for improving general mood or treating clinical depression, omega-3 fatty acids, St John’s wort, S-adenosyl-methionine (SAMe), N-acetyl cysteine (NAC) and zinc are the most researched and commonly used.

Omega-3 fatty acids

There are three types of omega-3 fatty involved in human physiology. They are important for normal metabolism.

Epidemiological studies show that low dietary intake of omega-3 oils from fish may be related to increased risk of depressive symptoms. A review of dozens of clinical trials on major depression that assessed the efficacy of these fatty acids alone or in combination with antidepressants, supported their use in depression.

And a meta-analysis combining the results of five similar studies found a significant effect in favour of omega-3 fatty acids for reducing bipolar depression.

SAMe

S-adenosyl-methionine (SAMe) is a naturally occurring compound found in almost every tissue and fluid in the body that’s involved in processes, such as producing and breaking down brain chemicals including serotonin, melatonin, and dopamine.

Double-blind studies show injected and oral preparations (between 800 milligrams to 1600 milligrams) of SAMe are as effective as antidepressants, and tend to produce relatively fewer adverse effects. SAMe also improves the response to antidepressant medication.

It’s a little expensive but SAMe appears well tolerated with only mild adverse effects such as headaches, restlessness, insomnia and gastrointestinal upsets.

St John’s wort

St John’s wort (Hypericum perforatum) is a flowering plant that has a long history of medicinal use. It’s been studied for treating depression in over 40 clinical trials of varying methodological quality.

A 2008 Cochrane review of 29 trials involving 5,489 patients analysed comparisons of St John’s wort with placebo or dummy pills and with antidepressants. It showed people were significantly more likely to respond to St John’s wort than to placebo. In the same analysis, St John’s wort had an equivalent effect to antidepressants.

Because of the risk of drug interactions, people taking other medicines should only use St John’s wort with low amounts of the plant chemical hyperforin, which has effects on drug levels in the body (see an appropriate health professional for advice on this).

The supplement should not be taken with antidepressants as it can cause serotonin syndrome, a potentially fatal nervous system event.

NAC

N-acetyl cysteine (NAC) is an amino acid with strong antioxidant properties that has a history of use in the management of paracetamol overdose. It’s been found to significantly reduce depression in bipolar disorder.

In a 24-week placebo-controlled trial of 75 people with bipolar disorder, one gram of NAC twice a day significantly reduced depression. The supplement appears to have no significant adverse reactions but is currently only available from compounding pharmacies or from overseas.

Zinc

Zinc is a mineral found in some food, and there’s emerging evidence that it improves depressed mood.

A 2012 review of randomised controlled trials found two 12-week trials, with sample sizes of 60 and 20 people, showed zinc as an adjunct to antidepressants significantly lowered depression.

Zinc can be safely prescribed in doses up to 30 milligrams a day, although it should have amino acid another aid to improve absorption. While zinc is a fairly safe supplement, it may cause nausea on an empty stomach.

A cautionary note

This is a very basic overview of the evidence for these five supplements, and people considering their use should get health professional advice before starting to take them.

The studies mentioned here tend to support that “add-on” prescription of a range of nutrients, such as omega-3 fatty acids, SAMe, folic acid, N-acetyl cysteine and zinc, with various medicines, such as antidepressants, have a beneficial effect in improving treatment beyond that of placebo. But again, be sure to seek medical advice before combining any supplements with medications.

Clinical trials have demonstrated little or no effect for valerian in insomnia, St John’s wort in anxiety disorders or attention deficit hyperactivity disorder, n-acetyl cysteine or docosahexaenoic acid (DHA) fatty acids for unipolar depression, and omega-3 for bipolar mania, among others.

The majority of Australians, especially women, already take a range of nutrient and herbal-based supplements for a number of mental health problems. But, consumers should be mindful of the evidence for their effectiveness and differences between the quality and standardisation of supplements, as well as potential drug interactions.

Click here for information on participating in a clinical trial, running in Brisbane and Melbourne, assessing the use of nutraceuticals for people who are depressed.

The Conversation


Dr Sarris is involved in academic research of natural products in the treatment of psychiatric disorders. This publication is not supported by any direct funding and no potential financial benefit is expected as a result of this publication. Dr Sarris has received honoraria, research support, royalties, or consultancy or travel grant funding from Integria Health, Blackmores, Bioceuticals, South Pacific Elixers, Pepsico, HealthEd, Soho-Flordis, Pfizer, Elsevier, the Society for Medicinal Plant and Natural Product Research, CR Roper Fellowship, an the National Health and Medical Research Council.

This article was originally published on The Conversation.
Read the original article.

TweetSendScanShareSendPinShareShareShareShareShare

RELATED

Biomarkers in spinal fluid may flag frontotemporal dementia before symptoms emerge
Dementia

Biomarkers in spinal fluid may flag frontotemporal dementia before symptoms emerge

May 28, 2025

A large-scale analysis of spinal fluid has identified distinct protein patterns that may allow for earlier diagnosis and monitoring of frontotemporal dementia, a midlife-onset brain disorder often misdiagnosed due to its wide-ranging symptoms and lack of biomarkers.

Read moreDetails
Robot-assisted therapy improves communication in autistic children
Autism

Robot-assisted therapy improves communication in autistic children

May 28, 2025

A new randomized controlled trial shows that a humanoid robot can significantly improve social communication and interaction in children with autism. The study found that robot-led therapy was more effective than both human-only intervention and no intervention at all.

Read moreDetails
High caffeine intake linked to greater psychological distress in people with depression
Caffeine

High caffeine intake linked to greater psychological distress in people with depression

May 28, 2025

A new study finds that individuals with a history of depression who consume high amounts of caffeine tend to report greater psychological distress. Genetic differences also appear to influence how much caffeine people drink and how sensitive they are.

Read moreDetails
Menopause symptoms may signal future dementia risk, new research suggests
Dementia

Menopause symptoms may signal future dementia risk, new research suggests

May 27, 2025

Hot flashes and brain fog during menopause may be warning signs of more than just hormonal changes. A new study links the number of menopause symptoms to future risks of cognitive decline and behavioral changes tied to dementia.

Read moreDetails
Cannabidiol shows promise for treating Alzheimer’s in mice by targeting brain hyperactivity
Alzheimer's Disease

Cannabidiol shows promise for treating Alzheimer’s in mice by targeting brain hyperactivity

May 26, 2025

In a study using an Alzheimer’s disease mouse model, researchers found that cannabidiol reduced memory loss and brain abnormalities. The compound worked by enhancing the function of glycine receptors, which help regulate neuronal activity in the brain's memory center.

Read moreDetails
Study suggests shared genetic roots between psychiatric disorders and COVID-19 risk
COVID-19

Study suggests shared genetic roots between psychiatric disorders and COVID-19 risk

May 26, 2025

A large-scale genetic study links depression, PTSD, and ADHD to increased COVID-19 risk, highlighting shared biological pathways involving immunity and stress response.

Read moreDetails
Ultra-processed foods linked to higher risk of stroke and cognitive decline
Mental Health

Ultra-processed foods linked to higher risk of stroke and cognitive decline

May 26, 2025

A large U.S. study found that diets high in ultra-processed foods were associated with an increased risk of stroke and cognitive impairment—independent of overall diet quality—suggesting that food processing itself may harm brain health over time.

Read moreDetails
A common childhood virus could be silently fueling Alzheimer’s disease in old age
Alzheimer's Disease

A common childhood virus could be silently fueling Alzheimer’s disease in old age

May 25, 2025

A virus best known for causing cold sores may dramatically increase the risk of Alzheimer’s in people with a specific gene variant. New evidence suggests herpes reactivation in the brain may trigger the destructive changes seen in the disease.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Neuroscientists discover specific brain cells that enable intelligent behavior

Encountering romantic temptation nudges men and women toward different types of purchases

Biomarkers in spinal fluid may flag frontotemporal dementia before symptoms emerge

Robot-assisted therapy improves communication in autistic children

High caffeine intake linked to greater psychological distress in people with depression

Scientists identify delusion-like cognitive biases that predict conspiracy theory belief

Only a specific dose of psilocybin induces lasting antidepressant-like effects, study suggests

Menopause symptoms may signal future dementia risk, new research suggests

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy